BridgeMD
New treatment option for Hospital Readmissions of Elderly Patients
Official title Geriatric Transitional Care for Older Patients Discharged From the Emergency Department: Impact on Early Readmissions
ClinicalTrials.gov ID: NCT05814328
What this study is testing
- What it's testing
- Elderly adults have high rates of emergency department (ED) visits. Specificities of this population challenge organizations of care in the ED, and older adults are at risk of pejorative outcomes after an ED stay.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 75 and older
You may be able to join if
- Patient admitted to the emergency departement over 75 years old and living at home (including independent residence)
- Patient admitted to the Emergency Reception Service (ERS) for less than 48 hours for whom a return home has been decided
- Identified at risk of readmissions to the emergency departement with a Triage Risk Screening Tool (TRST) score \> 2.
- Consent to the study possible at the time of his visit to the emergency room by the patient or a caregiver present at the time of inclusion.
- Patient affiliated with a social security (beneficiary or partner)
You likely can't join if
- Person living in an nursing home
- Severe cognitive impairment according to DSM V criteria and absence of a close relative at the time of inclusion
- Unstabilized psychiatric pathology and absence of relatives at the time of inclusion
- Language barrier and absence of relatives at the time of inclusion
- Person under guardianship, under legal safeguard measure, deprived of liberty by judicial or administrative decision, persons subject to psychiatric...
- Patient under state medical assistance
See the full eligibility criteria
- Patient admitted to the emergency departement over 75 years old and living at home (including independent residence)
- Patient admitted to the Emergency Reception Service (ERS) for less than 48 hours for whom a return home has been decided
- Identified at risk of readmissions to the emergency departement with a Triage Risk Screening Tool (TRST) score \> 2.
- Consent to the study possible at the time of his visit to the emergency room by the patient or a caregiver present at the time of inclusion.
- Patient affiliated with a social security (beneficiary or partner)
- Person living in an nursing home
- Severe cognitive impairment according to DSM V criteria and absence of a close relative at the time of inclusion
- Unstabilized psychiatric pathology and absence of relatives at the time of inclusion
- Language barrier and absence of relatives at the time of inclusion
- Person under guardianship, under legal safeguard measure, deprived of liberty by judicial or administrative decision, persons subject to psychiatric care without their consent, persons admitted to a health or social...
- Patient under state medical assistance
- Patient already included in the research
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 75 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.